Qian Yuan
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Efficient healing of diabetic wounds by MSC-EV-7A composite hydrogel via suppression of inflammation and enhancement of angiogenesis.
Journal: Biomaterials science
Published: February 20, 2024
LncRNA expression profiling in exosomes derived from synovial fluid of patients with rheumatoid arthritis.
Journal: International immunopharmacology
Published: October 30, 2023
Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation.
Journal: Theranostics
Published: August 13, 2023
Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: April 01, 2023
Improved Prediction of Knee Osteoarthritis by the Machine Learning Model XGBoost.
Journal: Indian journal of orthopaedics
Published: March 13, 2023
A Preliminary Study on Microbiota Characteristics of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Nodules Based on Metagenomic Next-Generation Sequencing.
Journal: Biomedicines
Published: January 18, 2023
Author Correction: A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling.
Journal: Nature communications
Published: November 05, 2022
Targeting the Akt/PI3K/mTOR signaling pathway for complete eradication of keloid disease by sunitinib.
Journal: Apoptosis : an international journal on programmed cell death
Published: June 07, 2022
Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors.
Journal: Biomaterials science
Published: February 16, 2022
Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma.
Journal: Acta histochemica
Published: November 05, 2021
EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 12, 2021
Last Updated: 09/26/2026